Showing results (91-100 of 103) with videos related to
Sort By:
Pageof 11
Nature|September 24, 2020
Light-driven post-translational installation of reactive protein side chainsBrian Josephson, Charlie Fehl, Patrick G Isenegger, et al.Angewandte Chemie (International Ed. in English)|October 5, 2017
Discovery of a Highly Selective Cell-Active Inhibitor of the Histone Lysine Demethylases KDM2/7Philip A Gerken, Jamie R Wolstenhulme, Anthony Tumber, et al.EMBO Reports|April 5, 2011
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylasesRasheduzzaman Chowdhury, Kar Kheng Yeoh, Ya-Min Tian, et al.Journal of Medicinal Chemistry|November 29, 2021
First-in-Class Inhibitors of the Ribosomal Oxygenase MINA53Radosław P Nowak, Anthony Tumber, Eline Hendrix, et al.Angewandte Chemie (International Ed. in English)|November 16, 2018
Design, Synthesis and Characterization of Covalent KDM5 InhibitorsSaleta Vazquez-Rodriguez, Miranda Wright, Catherine M Rogers, et al.Chemical Science|February 14, 2018
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trialsTzu-Lan Yeh, Thomas M Leissing, Martine I Abboud, et al.ACS Chemical Biology|July 10, 2019
The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone DemethylasesMartin Roatsch, Inga Hoffmann, Martine I Abboud, et al.Epigenetics & Chromatin|March 8, 2017
Assessing histone demethylase inhibitors in cells: lessons learnedStephanie B Hatch, Clarence Yapp, Raquel C Montenegro, et al.Cell Chemical Biology|March 7, 2017
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma CellsAnthony Tumber, Andrea Nuzzi, Edward S Hookway, et al.Cancer Research|April 6, 2021
JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate CancerAlec Paschalis, Jonathan Welti, Antje J Neeb, et al.Pageof 11